Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by leveraging digital technologies to facilitate remote patient participation. This patient-centric approach not only benefits participants but also ensures more inclusive and robust study results while reducing the workload for investigators. In the aftermath of the pandemic, a hybrid model is emerging that seamlessly integrates technology with traditional site workflows, ushering in a new era of clinical trials that harnesses the strengths of both approaches. In a financially constrained environment, DCT platform providers are looking to strike a balance between client satisfaction and cost reduction. They prioritize delivering comprehensive solutions that include real-world evidence, integration with sensors and wearables, and tools dedicated to enhancing patient engagement and retention throughout the trial process.

This compendium provides detailed and fact-based snapshots of 22 DCT providers. Each profile offers a comprehensive picture of the provider’s offerings, technology solutions, key clients, recent developments, and investments.

Scope

Industry: Life sciences

Geography: global

Contents

This report features 22 DCT platform provider profiles and includes:

• Company overview: the company’s mission, client base, and revenue split across buyer segment and geographies
• Case studies demonstrating DCT capabilities
• Solutions/Products enabling DCT capabilities
• Recent product developments, partnerships, and investment areas

Membership(s)

Clinical Development Technology

Outsourcing Excellence